Consequently, imiquimod induced a significant increase in the number of key-memory-phenotype cells and larger percentages of CD127+ (IL-7R) T cells in lymphoma, whereas imiquimod and CpG-ODN synergistically induced the growth of effector CD8+ T cells. Here, IL7R is linked to lymphoma.